Effect of statins on breast cancer recurrence and mortality: a review
Renae D Van Wyhe,1,2 Omar M Rahal,1 Wendy A Woodward1 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2Baylor College of Medicine, Houston, TX, USA Abstract: Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, are medications that have been u...
Guardado en:
Autores principales: | Van Wyhe RD, Rahal OM, Woodward WA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f86c35c0ce7e4f029e274d73511b9296 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statins and risk of breast cancer recurrence
por: Sakellakis M, et al.
Publicado: (2016) -
Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins
por: Peng-Fei Zhu, et al.
Publicado: (2021) -
Opioids and Breast Cancer Recurrence: A Systematic Review
por: Merlino Lucia, et al.
Publicado: (2021) -
Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
por: Hana Kim, et al.
Publicado: (2021) -
Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
por: Tuuminen R, et al.
Publicado: (2016)